Search
for
Did you mean Immune Checkpoint Inhibitors?
Sort by
Research 30 of 1000+
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Immune checkpoint inhibitor‐related alopecia: Insight into the pathophysiology utilizing non‐invasive diagnostic techniques
- [Translated article] Characteristics, Management, and Prognostic Implications of Adverse Effects of Immune Checkpoint Inhibitors: A Systematic Review
- Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- IMMUNE-RELATED SKIN TOXICITIES TO CHECKPOINT INHIBITORS THERAPY
- 806 Immune related gene expression analysis of de novo primary skin cancers in patients receiving immune checkpoint inhibitors for advanced cSCC
- Association of prior 5-α-reductase inhibitor exposure with ICI benefit in metastatic RCC: Multicentre cohort with single-cell immune profiling.
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Eosinophilic folliculitis of the scalp associated with PD‐1/PDL1 inhibitors
- Revisión sistemática de los efectos adversos cutáneos causados por fármacos inhibidores de los puntos de control inmunitario: características, manejo y pronóstico
- Immune Microenvironment of Hair Follicles in Tumor Immunotherapy
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- The role of lymphocytes in the development and treatment of alopecia areata
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- Nivolumab-Induced Alopecia Areata: A Case Report and Literature Review
- Wnt is back in drugmakers' sights, but is it druggable?
- Eyelash trichomegaly complicating pembrolizumab for colorectal cancer
- Resolution of paraneoplastic alopecia areata following nivolumab in a patient with metastatic melanoma
- Cutaneous lupus erythematosus induced by tislelizumab
- Alopecia Areata in a Patient Receiving Cemiplimab for Metastatic Cutaneous Squamous Cell Carcinoma
- Cemiplimab-Induced Alopecia Areata
- 44391 ICI Therapy Toxicities in Psoriasis
- Comprehensive Genomic Profiling of Cutaneous Adnexal Carcinomas: A Genomic Landscape Study